ATS
GILD icon

Ashton Thomas Securities’s Gilead Sciences GILD Stock Holding History

Ashton Thomas Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
2,355
+153
+7% +$20.2K 0.04% 259
2026
Q1 		$307K Buy
2,202
+153
+7% +$21.4K 0.04% 296
2025
Q4 		$251K Buy
2,049
+237
+13% +$28.8K 0.05% 231
2025
Q3 		$201K Buy
+1,812
New +$206K 0.03% 315
2024
Q4 		– Sell
-1,214
Closed -$102K – 616
2024
Q3 		$102K Buy
+1,214
New +$92.6K 0.02% 326

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ashton Thomas Securities's GILD Position: Q2 2026 in Review

Ashton Thomas Securities increased its Gilead Sciences (GILD) stake by 6.9% in Q2 2026, buying an estimated $20.2K and bringing the position to 2,355 shares worth $289K. The position accounts for 0.04% of the portfolio, ranked #259.

Ashton Thomas Securities first reported a position in GILD in Q3 2024 and has held it in 5 quarters since. The position peaked at $307K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ashton Thomas Securities held 2,355 shares of Gilead Sciences worth $289K as of Q2 2026.
  • Ashton Thomas Securities bought 153 Gilead Sciences shares in Q2 2026, an estimated $20.2K.
  • Gilead Sciences made up 0.04% of Ashton Thomas Securities's portfolio in Q2 2026, its #259 holding.
  • Ashton Thomas Securities first reported a position in Gilead Sciences in Q3 2024 and has held it in 5 quarters since.
  • Ashton Thomas Securities's Gilead Sciences position peaked at $307K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ashton Thomas Securities's 13F filing for Q2 2026, filed 27 Jul 2026.